Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Return on Equity (2018 - 2021)

Cogent Biosciences (COGT) has 4 years of Return on Equity data on record, last reported at 0.3% in Q3 2021.

  • For Q3 2021, Return on Equity fell 4692.0% year-over-year to 0.3%; the TTM value through Sep 2021 reached 0.3%, down 4692.0%, while the annual FY2020 figure was 0.62%, 8.0% up from the prior year.
  • Return on Equity reached 0.3% in Q3 2021 per COGT's latest filing, up from 0.45% in the prior quarter.
  • Across five years, Return on Equity topped out at 46.62% in Q3 2020 and bottomed at 1.25% in Q3 2019.
  • Average Return on Equity over 4 years is 3.19%, with a median of 0.75% recorded in 2020.
  • Peak YoY movement for Return on Equity: surged 4787bps in 2020, then plummeted -4692bps in 2021.
  • A 4-year view of Return on Equity shows it stood at 0.55% in 2018, then tumbled by -94bps to 1.06% in 2019, then rose by 27bps to 0.77% in 2020, then soared by 62bps to 0.3% in 2021.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.3% in Q3 2021, 0.45% in Q2 2021, and 0.38% in Q1 2021.